Del-Sette Capital Management »

Crispr Therapeutics shares owned by Del-Sette Capital Management

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Del-Sette Capital Management from 13F filings

Historical chart of Del-Sette Capital Management investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Del-Sette Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Del-Sette Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.1M 63k 64.81
2025-06-30 $3.1M 64k 48.64
2024-06-30 $2.0M 37k 54.01
2023-09-30 $1.5M 34k 45.39
2023-06-30 $1.9M 34k 56.14
2023-03-31 $1.1M 24k 45.23

More positions owned by Del-Sette Capital Management

Alps Etf Tr Intl Sec Dv Dog (IDOG)
Alps Etf Tr Em Sect Div Dg (EDOG)
First Tr Exchange-traded SHS (FDL)
Ishares Tr Msci Emg Mkt Etf (EEM)
Wisdomtree Tr Us Smallcap Divd (DES)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Applovin Corp Com Cl A (APP)
Vanguard Admiral Fds SMLCP 600 GRTH (VIOG)
Dimensional Etf Trust Internatnal Val (DFIV)
NVIDIA Corporation (NVDA)
Pimco Etf Tr Active Bd Etf (BOND)
Cambria Etf Tr Global Value Etf (GVAL)
Crispr Therapeutics Namen Akt (CRSP)
Invesco Exch Traded Fd Tr Ii Dorsey Wrgt Dvlp (PIZ)
Spdr Index Shs Fds Euro Stoxx 50 (FEZ)

View all positions for Del-Sette Capital Management

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Capital Research and Management Company - Division 3
Orbis Allan Gray
State Street Corporation
T. Rowe Price Investment Management
UBS Group
Vanguard Group
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Geode Capital Management
Susquehanna International
Sr One Capital Management
Citadel Advisors
FMR

View all funds holding Crispr Therapeutics